Last reviewed · How we verify
Physiopathology Endpoint Classification
At a glance
| Generic name | Physiopathology Endpoint Classification |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- Venous Congestion And Delirium After Cardiac Surgery
- Trial Readiness and Endpoint Assessment in Congenital and Childhood Myotonic Dystrophy
- Study of One Protein Implicated in Wegener Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: